These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 34596153)
21. A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma. Peng Y; Wu S; Xu Z; Hou D; Li N; Zhang Z; Wang L; Wang H Cancer Med; 2021 Aug; 10(16):5499-5512. PubMed ID: 34196116 [TBL] [Abstract][Full Text] [Related]
22. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma. Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133 [TBL] [Abstract][Full Text] [Related]
23. Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma. Pang S; Zhao S; Dongye Y; Fan Y; Liu J Cell Biol Int; 2024 Jun; 48(6):777-794. PubMed ID: 38440906 [TBL] [Abstract][Full Text] [Related]
24. Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma. Chen Q; Li ZL; Fu SQ; Wang SY; Liu YT; Ma M; Yang XR; Xie WJ; Gong BB; Sun T Aging (Albany NY); 2021 Jan; 13(3):3926-3944. PubMed ID: 33461173 [TBL] [Abstract][Full Text] [Related]
25. A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients. Tao Z; Zhang E; Li L; Zheng J; Zhao Y; Chen X Bioengineered; 2021 Dec; 12(1):4259-4277. PubMed ID: 34304692 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of a gene signature in clear cell renal cell carcinoma. Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359 [TBL] [Abstract][Full Text] [Related]
27. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma. Lu Q; Xi P; Xu S; Zhang Z; Gong B; Liu J; Zhu Q; Sun T; Zhu S; Chen R Aging (Albany NY); 2024 Mar; 16(7):6118-6134. PubMed ID: 38546385 [TBL] [Abstract][Full Text] [Related]
28. A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma. Wu J; Zhang F; Zhang J; Sun Z; Hao C; Cao H; Wang W Technol Cancer Res Treat; 2021; 20():15330338211027923. PubMed ID: 34159861 [TBL] [Abstract][Full Text] [Related]
30. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma. Zhao E; Bai X Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701 [TBL] [Abstract][Full Text] [Related]
31. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma. Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284 [TBL] [Abstract][Full Text] [Related]
32. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968 [TBL] [Abstract][Full Text] [Related]
33. Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma. Li P; Ren H; Zhang Y; Zhou Z Medicine (Baltimore); 2018 Aug; 97(33):e11839. PubMed ID: 30113474 [TBL] [Abstract][Full Text] [Related]
34. CD276 is a promising biomarker for the prognosis of clear cell renal cell carcinoma. Yu YH; Xu JH; Chen H; Lin YX; Ou-Yang J; Zhang ZY Kaohsiung J Med Sci; 2024 Oct; 40(10):926-933. PubMed ID: 39210603 [TBL] [Abstract][Full Text] [Related]
35. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma. Ma W; Zhong M; Liu X Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862 [TBL] [Abstract][Full Text] [Related]
36. Identification of a Hypoxia-Related Gene Model for Predicting the Prognosis and Formulating the Treatment Strategies in Kidney Renal Clear Cell Carcinoma. Ning XH; Li NY; Qi YY; Li SC; Jia ZK; Yang JJ Front Oncol; 2021; 11():806264. PubMed ID: 35141153 [TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma. Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694 [TBL] [Abstract][Full Text] [Related]
38. DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts. Ha M; Jeong H; Roh JS; Lee B; Han ME; Oh SO; Sohn DH; Kim YH Urol Oncol; 2019 Oct; 37(10):735-741. PubMed ID: 31377166 [TBL] [Abstract][Full Text] [Related]
39. 53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: a study based on TCGA and SEER database. Tang F; Lu Z; He C; Zhang H; Wu W; He Z BMC Cancer; 2021 May; 21(1):638. PubMed ID: 34051738 [TBL] [Abstract][Full Text] [Related]
40. A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma. Gu J; Zhang X; Peng Z; Peng Z; Liao Z Sci Rep; 2023 Nov; 13(1):18922. PubMed ID: 37919459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]